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background: Treatment of heart failure is resource intensive. However, little is known about the costs of pediatric heart failure related 
hospitalizations (HFRH) or how costs have changed over time. Using charges as a proxy for cost, we tested the hypothesis that pediatric HFRH costs 
would increase over time.
methods: A retrospective analysis of the 2000, 2003, 2006, and 2009 Healthcare Cost and Utilization Project Kids’ Inpatient Database was 
performed on pediatric HFRH. This nationwide database is the largest all-payer administrative database of pediatric admissions in the US. Charges 
were adjusted for inflation.
results: There were 6,478 pediatric heart failure admissions in 2000 and 9,560 in 2009. Median HFRH charges rose from $35,079 (interquartile 
range [IQR], $11,697-$91,357) in 2000 to $72,087 (IQR, $23,512-$179,742) in 2009 (p<0.0001). The greatest charges were incurred in patients 
on extracorporeal membrane oxygenation ($442,134 [IQR, $259,704-$684,806] vs $53,998 [IQR, $17,437-$136,400]) or a ventricular assist 
device ($462,647 [IQR, $212,083-$776,572] vs $55,151 [IQR, $17,688-$141,421]). Comorbidities, including sepsis ($207,511 [IQR, $80,429-
$436,263] vs $48,995 [IQR, $16,138-$121,013]), renal failure ($180,624 [IQR, $59,064-$416,706] vs $52,812 [IQR, $16,889-$132,310), 
stroke ($198,260 [IQR, $81,563-$438,410] vs $54,974 [IQR, $17,639-$141,111]) and respiratory failure ($146,200 [IQR, $57,838-$324,518] 
vs $48,797 [IQR, $15,847-$123,090]), were also associated with greater charges (all p<0.0001). Comorbidities and the use of mechanical 
support increased over time. However, after adjusting for these factors, demographics, and length of stay, later calendar year remained significantly 
associated with greater charges (p<0.0001).
conclusions: From 2000 to 2009 there has been an almost two-fold increase in pediatric HFRH charges, after adjusting for inflation. Although 
major comorbidities and use of mechanical support account for some of this increase, later calendar year remained independently associated with 
greater charges. This study highlights the need to develop cost-effective therapies in this population.
